NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).

Antoine BrouquetJean-Baptiste BachetFlorence HuguetMehdi KarouiPascal ArtruCharles SabbaghJérémie H LefèvreDewi VernereyChristophe MarietteEric VicautStephane Benoistnull null

Published in: BMC cancer (2020)

ClinicalTrials.gov NCT03875781 (March 15, 2019). Version 1.1.

Keyphrases

locally advanced
phase iii
rectal cancer
double blind
open label
neoadjuvant chemotherapy
clinical trial
phase ii study
placebo controlled
squamous cell carcinoma
phase ii
patients undergoing
radiation therapy
psychometric properties
cross sectional
study protocol
radiation induced
randomized controlled trial